Greenland Mines Receives 6-Month Nasdaq Extension to Avoid Delisting
GRML has more than doubled off its 52-week low of $0.114 on light trading volume (0.4× avg).
Summary
Greenland Mines Ltd has been granted an additional six-month extension by Nasdaq until September 14, 2026, to regain compliance with the minimum $1 bid price requirement, preventing immediate delisting.
Key Events · Corporate Governance and Compliance · GRML
-
Nasdaq Extension Granted
Greenland Mines received an additional six-month extension from The Nasdaq Stock Market LLC to meet the minimum $1.00 bid price requirement.
-
New Compliance Deadline
The company now has until September 14, 2026, to achieve a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.
-
Delisting Risk Remains
Failure to regain compliance by the new deadline will result in the delisting of the company's common stock from Nasdaq.
-
Follows Prior Non-Compliance Notice
This extension follows an initial 180-day compliance period that expired on March 18, 2026, after the company was first notified of non-compliance on September 19, 2025.
Analysis · GRML · Life Sciences
This 8-K filing provides a critical update on Greenland Mines' Nasdaq listing status. While the extension prevents immediate delisting, the company still faces the significant challenge of raising its stock price above $1.00 for 10 consecutive business days by September 14, 2026. Given the current stock price of $0.41875, this represents a substantial hurdle. Failure to comply by the new deadline would result in delisting, severely impacting the company's liquidity and investor confidence, especially for a micro-cap company that recently rebranded and announced a new strategic direction. Investors should monitor the company's progress towards compliance closely.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 40.9% of the 1143 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.37%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $0.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.8M. The 52-week trading range was $0.11 to $3.91. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.